Moxetumomab Pasudotox

Active Ingredient

All Co-Formulated Excipients (0 Total)

None

Available Products (2 Total)

Product name Manufacturer Route Approved Date
1. Lumoxiti Astrazeneca Pharmaceuticals Lp Intravenous
2. Lumoxiti Innate Pharma, Inc. Intravenous

Comments